Intellia Therapeutics (NTLA) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.52
-1.39
-1.25
-1.12

Details

Expected EPS
-1.39013
Actual EPS
-1.34
Surprise EPS
0.05
Surprise Percent
+3.61%

Description

⁨Intellia Therapeutics⁩ (⁦NTLA⁩) has reported earnings of ⁦-1.34⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts